CA2020209A1 - Surfactant tres concentre, a faible viscosite - Google Patents

Surfactant tres concentre, a faible viscosite

Info

Publication number
CA2020209A1
CA2020209A1 CA2020209A CA2020209A CA2020209A1 CA 2020209 A1 CA2020209 A1 CA 2020209A1 CA 2020209 A CA2020209 A CA 2020209A CA 2020209 A CA2020209 A CA 2020209A CA 2020209 A1 CA2020209 A1 CA 2020209A1
Authority
CA
Canada
Prior art keywords
low viscosity
highly concentrated
concentrated surfactant
surfactant suspension
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2020209A
Other languages
English (en)
Other versions
CA2020209C (fr
Inventor
Bernd Disse
Eberhard Weller
Robert Becker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of CA2020209A1 publication Critical patent/CA2020209A1/fr
Application granted granted Critical
Publication of CA2020209C publication Critical patent/CA2020209C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
CA002020209A 1989-07-04 1990-06-29 Surfactant tres concentre, a faible viscosite Expired - Fee Related CA2020209C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3921954A DE3921954A1 (de) 1989-07-04 1989-07-04 Niedrig-viskose, hochkonzentrierte surfactant-suspension
DEP3921954.2 1989-07-04

Publications (2)

Publication Number Publication Date
CA2020209A1 true CA2020209A1 (fr) 1991-01-05
CA2020209C CA2020209C (fr) 2000-09-12

Family

ID=6384269

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002020209A Expired - Fee Related CA2020209C (fr) 1989-07-04 1990-06-29 Surfactant tres concentre, a faible viscosite

Country Status (23)

Country Link
US (1) US5552161A (fr)
EP (1) EP0406732B1 (fr)
JP (1) JP3103582B2 (fr)
KR (1) KR0162642B1 (fr)
AT (1) ATE122891T1 (fr)
AU (1) AU623538B2 (fr)
CA (1) CA2020209C (fr)
DD (1) DD297916A5 (fr)
DE (2) DE3921954A1 (fr)
DK (1) DK0406732T3 (fr)
ES (1) ES2072940T3 (fr)
FI (1) FI95655C (fr)
HU (1) HU205004B (fr)
IE (1) IE68448B1 (fr)
IL (1) IL94961A (fr)
NO (1) NO180620C (fr)
NZ (2) NZ234341A (fr)
PH (1) PH30232A (fr)
PL (1) PL164434B1 (fr)
PT (1) PT94574B (fr)
RU (1) RU2077880C1 (fr)
UA (1) UA26313A (fr)
ZA (1) ZA905182B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
WO2001019392A1 (fr) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combinaison de c1-inh et d'un agent tensioactif pulmonaire pour le traitement des troubles respiratoires
EP1249244A1 (fr) * 2001-04-13 2002-10-16 Universiteit Gent Compositions thérapeutiques pour le traitement d'une maladie influencée par l'équilibre G-actin / F-actin, p.e. une maladie respiratoire
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
CN101171514B (zh) 2005-05-11 2011-07-20 雅玛山酱油株式会社 肺表面活性蛋白的稳定化方法
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
DE3369644D1 (en) * 1982-11-22 1987-03-12 Teijin Ltd Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Also Published As

Publication number Publication date
PL164434B1 (pl) 1994-07-29
DK0406732T3 (da) 1995-10-02
CA2020209C (fr) 2000-09-12
NZ242869A (en) 1997-05-26
IL94961A0 (en) 1991-06-10
EP0406732A2 (fr) 1991-01-09
ATE122891T1 (de) 1995-06-15
EP0406732B1 (fr) 1995-05-24
ZA905182B (en) 1992-03-25
RU2077880C1 (ru) 1997-04-27
IE68448B1 (en) 1996-06-26
NO180620B (no) 1997-02-10
PH30232A (en) 1997-02-05
HK1000277A1 (en) 1998-02-20
NZ234341A (en) 1992-07-28
JP3103582B2 (ja) 2000-10-30
KR0162642B1 (ko) 1998-12-01
HUT56274A (en) 1991-08-28
PT94574B (pt) 1997-02-28
NO902961L (no) 1991-01-07
FI95655C (fi) 1996-03-11
HU205004B (en) 1992-03-30
HU904077D0 (en) 1990-12-28
ES2072940T3 (es) 1995-08-01
DD297916A5 (de) 1992-01-30
AU5867690A (en) 1991-01-10
JPH0344332A (ja) 1991-02-26
PT94574A (pt) 1991-03-20
DE59009113D1 (de) 1995-06-29
IE902408A1 (en) 1991-06-19
DE3921954A1 (de) 1991-01-17
UA26313A (uk) 1999-08-30
KR910002427A (ko) 1991-02-25
EP0406732A3 (en) 1991-02-27
FI95655B (fi) 1995-11-30
FI903341A0 (fi) 1990-07-03
IL94961A (en) 1994-10-21
NO902961D0 (no) 1990-07-03
US5552161A (en) 1996-09-03
NO180620C (no) 1997-05-21
AU623538B2 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
TW329059B (en) Silica
ES8607727A1 (es) Procedimiento para la estabilizacion de preparados farmaceuticos en forma de suspensiones conteniendo sucralfato
AU2452088A (en) Plasma and recombinant protein formulations in high ionic strength media
AU5867690A (en) Low viscosity highly concentrated surfactant suspension
GEP19971155B (en) Contrast medium and method for its production
GR3007326T3 (fr)
AU7611096A (en) Precipitated silica having high sodium sulfate content
GB8701491D0 (en) Aqueous suspensions of calcium
EP1632248B8 (fr) Anticorps Anti-Interleukin-9 ou anticorps du récepteur Anti-Interleukin-9 pour le traitment de la hyper-réponse bronchique
AU589970B2 (en) Animal litter and process for the production thereof
GB9616896D0 (en) Pharmaceutical compositions
MY115710A (en) Desiccant composition
FR2677351B1 (fr) Suspension aqueuse concentree d'hydrate de calcium et son procede de preparation.
GB9101463D0 (en) Treatment of poisoning and compositions for use therein
AU7465298A (en) Process of increasing calcium content in an aqueous solution
AU3703795A (en) Chondrocyte cell-lines
GB2308830B (en) Air suspension system safety feature against fracture of the trailing arm
PL272154A1 (en) Apparatus for aqueous suspension and solution of calcium in particular of quicklime
GB2228399B (en) Process for enhancing the perceived strength of tobacco smoke
MX9706361A (es) Sales de carboxiamidas estables, de accion prolongada, composiciones que las contienen y el uso de las mismas.
PT101461A (pt) Nutriente liquido para recem-nascidos nutriente liquido para recem-nascidos
MY107599A (en) Sucralfate suspension compounds.
BG50666A1 (en) Means for soft leather filling
CS275419B2 (en) Suspension of locomotive's middle bogie with body
AU112023S (en) Cloth hanger

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed